|
MechanismPhosphates modulators |
|
|
|
|
Drug Highest PhasePhase 2 |
First Approval Ctry. / Loc.- |
First Approval Date- |
Study to Evaluate the Efficacy and Safety of PT20 in Subjects With Hyperphosphataemia and Dialysis Dependent Chronic Kidney Disease
The main purpose of this study is to see whether PT20 can help people with a high level of phosphate in their blood (called Hyperphosphatemia) that are being treated with dialysis for kidney disease.
100 Clinical Results associated with Phosphate Therapeutics Ltd.
0 Patents (Medical) associated with Phosphate Therapeutics Ltd.
100 Deals associated with Phosphate Therapeutics Ltd.
100 Translational Medicine associated with Phosphate Therapeutics Ltd.